drugset / Trial / NCT01447849

Lubiprostone and Mucus Secretion in Patients With Chronic Constipation

NCT01447849

RandomizedCrossoverDouble-blindTreatment

Summary

The investigators hypothesize that the symptoms of chronic constipation in some patients are developed due to diminished production and secretion of the alimentary tract mucus resulting in poor lubrication. Therefore, the investigators assume that administration of lubiprostone may restore this lubrication impairment by stimulation of mucus production and secretion within the gastrointestinal tract.

Timeline

Start
2011-08
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lubiprostone Small molecule 24 ug

Indications